Suppr超能文献

肠上皮细胞特异性 NHE3 敲除小鼠中增强的磷酸盐吸收。

Enhanced phosphate absorption in intestinal epithelial cell-specific NHE3 knockout mice.

机构信息

Department of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA.

Department of Biomedicine, Aarhus University, Aarhus, Denmark.

出版信息

Acta Physiol (Oxf). 2022 Feb;234(2):e13756. doi: 10.1111/apha.13756. Epub 2022 Jan 11.

Abstract

AIMS

The kidneys play a major role in maintaining P homeostasis. Patients in later stages of CKD develop hyperphosphatemia. One novel treatment option is tenapanor, an intestinal-specific NHE3 inhibitor. To gain mechanistic insight into the role of intestinal NHE3 in P homeostasis, we studied tamoxifen-inducible intestinal epithelial cell-specific NHE3 knockout (NHE3 ) mice.

METHODS

Mice underwent dietary P challenges, and hormones as well as urinary/plasma P were determined. Intestinal P uptake studies were conducted in vivo to compare the effects of tenapanor and NHE3 . Ex vivo P transport was measured in everted gut sacs and brush border membrane vesicles. Intestinal and renal protein expression of P transporters were determined.

RESULTS

On the control diet, NHE3 mice had similar P homeostasis, but a ~25% reduction in FGF23 compared with control mice. Everted gut sacs and brush border membrane vesicles showed enhanced P uptake associated with increased Npt2b expression in NHE3 mice. Acute oral P loading resulted in higher plasma P in NHE3 mice. Tenapanor inhibited intestinal P uptake acutely but then led to hyper-absorption at later time points compared to vehicle. In response to high dietary P , plasma P and FGF23 increased to higher levels in NHE3 mice which was associated with greater Npt2b expression. Reduced renal Npt2c and a trend for reduced Npt2a expression were unable to correct for higher plasma P .

CONCLUSION

Intestinal NHE3 has a significant contribution to P homeostasis. In contrast to effects described for tenapanor on P homeostasis, NHE3 mice show enhanced, rather than reduced, intestinal P uptake.

摘要

目的

肾脏在维持磷稳态中起着重要作用。CKD 晚期患者会发生高磷血症。一种新的治疗选择是 Tenapanor,一种肠道特异性 NHE3 抑制剂。为了深入了解肠道 NHE3 在磷稳态中的作用机制,我们研究了他莫昔芬诱导的肠道上皮细胞特异性 NHE3 敲除(NHE3 -/- )小鼠。

方法

小鼠接受饮食磷挑战,测定激素以及尿/血浆磷。在体内进行肠道磷摄取研究,以比较 Tenapanor 和 NHE3 的作用。在翻转肠囊和刷状缘膜囊泡中进行体外磷转运测量。测定肠道和肾脏磷转运蛋白的表达。

结果

在对照饮食下,NHE3 -/- 小鼠具有相似的磷稳态,但与对照小鼠相比,FGF23 降低约 25%。翻转肠囊和刷状缘膜囊泡显示磷摄取增加,与 NHE3 -/- 小鼠中 Npt2b 表达增加相关。急性口服磷负荷导致 NHE3 -/- 小鼠的血浆磷水平升高。与载体相比,Tenapanor 急性抑制肠道磷摄取,但随后在稍后时间点导致过度吸收。在高膳食磷的情况下,NHE3 -/- 小鼠的血浆磷和 FGF23 增加到更高水平,这与 Npt2b 表达增加有关。肾脏 Npt2c 表达减少,Npt2a 表达减少趋势,但不能纠正更高的血浆磷。

结论

肠道 NHE3 对磷稳态有重要贡献。与描述的 Tenapanor 对磷稳态的作用相反,NHE3 -/- 小鼠显示出增强而不是减少的肠道磷摄取。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/349f/9286053/fbca3dc9a175/APHA-234-0-g004.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验